SUNDAY, FEBRUARY 11
2:00 – 5:00 PM
AFTERNOON SHORT COURSES
MOSCONE SOUTH CONVENTION CENTER | SAN FRANCISCO
SC1: Translating CTCs and ctDNA for Clinical Use
Dana W.Y. Tsui, Ph.D., Assistant Attending Geneticist; Member, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Emmanuel Antonarakis, M.D., Associate Professor, Urologic Oncology, Johns Hopkins University
Sonya Parpart-Li, Ph.D., Team Lead, Product Development, Personal Genome Diagnostics
SC2: NGS Assay Selection, Validation and Compliance
Maria E. Arcila, M.D., Pathologist and Director, Diagnostic Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center (AMP Member)
Eric Duncavage, M.D., Assistant Professor, Pathology & Immunology, Washington University School of Medicine (AMP Hematopathology Subdivision Representative to the AMP 2018 Program Committee; Member)
Birgit Funke, Ph.D., FACMG, Vice President, Clinical Affairs, Veritas Genetics; Associate Professor of Pathology, Harvard Medical School (AMP Genetics Subdivision Chair and Representative to the AMP 2018 Board of Directors; Member)
SC3: Sequencing 101
Ryan Kim, Ph.D., President & CEO, Macrogen USA
SC4: Omic Technology for Cancer Immunotherapy
James Robert White, Ph.D., Founder, Resphera Biosciences
Xing Wang, Ph.D., President, R&D, Array Bridge Inc
Lauren Ritterhouse, M.D., PH.D., Assistant Professor of Pathology, Genomic and Molecular Pathology Division The University of Chicago Medicine & Biological Sciences
SC5: Coverage and Reimbursement for Advanced Diagnostics
Kurt Matthes, Vice President, RCM Reengineering and Service, Revenue Cycle Management, TELCOR, Inc.
Girish Putcha, M.D., Ph.D., Director of Laboratory Science, MolDx, Palmetto GBA
Becky Foster, Principal , Foster Health Care Consulting
SC6: Innovative Imaging Technologies for Patient CTCs
Stuart S. Martin, Ph.D., Professor of Physiology, Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine
SC7: Precision Medicine 101
Jeanette McCarthy, MPH, Ph.D., Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors
SUNDAY, FEBRUARY 11
5:30 – 8:30 PM
DINNER SHORT COURSES
MOSCONE SOUTH CONVENTION CENTER | SAN FRANCISCO
SC9: Clinical Informatics: Returning Results from Big Data
N. Sertac Kip, M.D., Ph.D., Director, Oncology, Mount Sinai Hospital (AMP Member)
Mark Routbort, M.D., Ph.D., Director, Computational and Integrational Pathology; Associate Professor, Hematopathology; Medical Director, Laboratory Informatics, UT MD Anderson Cancer Center (AMP Informatics Subdivision Representative to the AMP 2017 Clinical
Practice Committee; Member)
Stephen E. Lincoln, Senior Vice President, InVitae (AMP NGS Bioinformatics Pipeline Validation Working Group; Member)
SC10: Regulatory Compliance in Molecular Diagnostics
Melina Cimler, Ph.D., Senior Vice President, Quality & Regulatory, Adaptive Biotechnologies
Pamela L. Swatkowski, Director, Regulatory Affairs, Abbott Molecular, Inc.
SC11: Liquid Biopsy Technologies and Applications
John Simmons, Ph.D., Director, Translational Science & Diagnostics, Personal Genome Diagnostics
Hatim Husain, M.D., Physician, Medical Oncology, University of California, San Diego
SC12: Leveraging Cloud Technologies to Enable Large-Scale Integration of Human Genome and Clinical Outcomes Data
R. Mark Adams, Ph.D., CIO, Celmatix, Inc.
Anna T. Fernandez, Ph.D., PMP, Senior Associate, Civil Health – Informatics, Booz Allen Hamilton
Andrew FigPope, Data Engineer, Celmatix, Inc.
Sam Globus, Ph.D., Director of Scientific Operations, Celmatix, Inc.
Michael Keller, Ph.D., Senior Associate, Civil Health, Booz Allen Hamilton
Christopher Matta, Systems Engineer, Confluent, Inc.
SC13: Building the Bridge between Science and Commercialization: Leveraging KOLs
Lawrence J. Worden, Principal, IVD Logix
Charles Mathews, Principal, ClearView Healthcare Partners
Peggy Robinson, Vice President, Angle PLC
SC14: Development of Bioassays for Checkpoint Immunotherapy
Richard Somberg, Ph.D., Strategic Collaborations Manager, Promega Corporation
SC15: Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization
Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.
Patrice Allibert, Ph.D., CEO and President, GenePOC
Viktor Shkolnikov, Ph.D., Microfluidics, HP Labs
Marta Fernandez Suarez, Daktari Diagnostics & FIND
Kris Buchanan, CEO, Phase Three Product Development
MONDAY, FEBRUARY 12
8:00 – 11:00 AM
MORNING SHORT COURSES
MOSCONE SOUTH CONVENTION CENTER | SAN FRANCISCO
SC17: Commercialization Boot Camp: Manual for Success in Molecular Diagnostics
Harry Glorikian, MBA, Healthcare Consultant
Stan Skrzypczak, MBA, Vice President, Corporate Development and Reimbursement, Guardant Health, Inc.
Recommended Course Material: Commercializing Novel IVDs: A Comprehensive Manual for Success
Harry Glorikian, MBA, Healthcare Consultant; Author, Commercializing Novel IVD’s Content
Based on the Commercialization Bootcamp Course and experience, the Commercializing Novel IVDs: A Comprehensive Manual for Success, greatly expands on the fundamental topics everyone in or around the IVD industry needs to know - from product ideation and
design to regulation to planning for market entry and reimbursement. For companies just starting out, this book is like having your very own IVD reference manual at your fingertips, providing you with a comprehensive overview to help make the process
as smooth as possible. For those of you already in the field, it’s a guide that may help bring you up-to-date on the key trends impacting the industry, evolving regulatory issues, and changes that are impacting the way IVDs are marketed and
sold. I have tried to present not just the big picture, but highlight the details that might be critical for success. For more information, visit: InsightPharmaReports.com/Commercializing-Novel-IVDs-Report
SC18: Next-Generation Sequencing as a Diagnostics Platform>
Karl Voelkerding, M.D., Professor of Pathology, University of Utah School of Medicine
Eric Konnick, M.D., MS, FCAP, Acting Assistant Professor, Associate Director, Genetics and Solid Tumor Laboratory Department of Laboratory Medicine University of Washington
Larissa Furtado, M.D., Medical Director, Molecular Oncology, ARUP Laboratories
SC19: Murine Models for Pre-Clinical Studies in Immuno-Oncology
Michael Brehm, Ph.D., Associate Professor, The Robert and Sandra Glass Term Chair in Diabetes, Diabetes Center of Excellence, Program in Molecular Medicine, University of Massachusetts Medical School
Rosemary J. Akhurst, Ph.D., Professor and Director, Preclinical Therapeutics Core, UCSF Helen Diller Family Comprehensive Cancer Center
Barbara Joyce-Shaikh, Associate Principal Scientist, Merck Research Laboratories
SC20: Best Practices in Personalized and Translational Medicine
Corey Bakalarski, Ph.D., Scientist, Genentech
Shimul Chowdhury, PhD, DABMGG, CGMB, Director, Clinical Laboratory, Rady Children’s Institute for Genomic Medicine
Paul Fretter, Head of Computing Infrastructure for Science (CiS), NBI Partnership Ltd.
Ran Goshen, MD, PhD, Chief Medical Officer, Medial EarlySign
Gavin Stone, Vice President of Marketing, Edico Genome
Paul Trevithick, Director, Business Solutions, EPAM Systems
SC21: NGS for Infectious Disease Diagnostics
Charles Chiu, M.D., Ph.D., Associate Professor of Laboratory Medicine and Medicine, Division of Infectious Diseases at University of California, San Francisco, Director of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC), and Associate
Director of the UCSF Clinical Microbiology Laboratory
SC22: Cell-Based Biomarkers for Cancer Immunotherapy Discovery and Development
Nathan Standifer, Ph.D., Senior Scientist, Clinical Pharmacology and DMPK, MedImmune
Mark Edinger, Scientific Affairs Director, Flow Cytometry, Q2 Solutions
Iulian Pruteanu-Malinici, Ph.D., Biostatistics, Investigator II, Lab Head, Novartis Institutes for BioMedical Research (NIBR)
SC23: Chromosomal Mosaicism in Humans: Clinical Implications for Preimplantation Genetic Screening, Prenatal Diagnosis and Non-Invasive Prenatal Testing
Brynn Levy, Professor, Pathology & Cell Biology at CUMC; Director, Clinical Cytogenetics Laboratory; Co-Director, Division of Personalized Genomic Medicine, College of Physicians and Surgeons, Columbia University Medical Center, and the New York
Presbyterian Hospital
WEDNESDAY, FEBRUARY 14
6:00 – 9:00 PM
DINNER SHORT COURSES
HILTON SAN FRANCISCO UNION SQUARE
SC25: Detection and Characterization of Circulating Biomarkers
Catherine Alix-Panabières, Ph.D., Director, Laboratory of Rare Human Circulating Cells (LCCRH), Cellular and Tissular Biopathology of Cancers, University Medical Center of Montpellier
Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg
SC26: Multiplexing Single Cell Analysis: A Combined Effort
Junyue Cao, Research Assistant, Jay Shendure Laboratory, Genomic Science, University of Washington
Ryan Mulqueen, Research Scientist, Brian J. O’Roak and Andrew Adey Laboratories, Molecular and Medical Genetics, Oregon Health & Science University
Kristof Torkenczy, Research Scientist, Andrew Adey Laboratory, Department of Molecular and Medical Genetics, Oregon Health & Science University
SC27: CRISPR-Based Gene Editing for Drug Discovery & Targeted Therapies
Clifford Steer, M.D., Professor of Medicine and, Genetics, Cell Biology, and Development; Director, Molecular Gastroenterology Program, University of Minnesota Medical School
Arthur L. Shaffer III, Ph.D., Staff Scientist, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health
Daniel P. Dever, Ph.D., Instructor, Laboratory of Dr. Matthew Porteus, Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford University Medical Center
SC28: Mastering Variant Interpretation
Jeanette McCarthy, MPH, Ph.D., Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors